The World Health Organization says that stopping the COVID-19 pandemic will require at least 70% of the world’s 7.8 billion to have immunity to the SARS-CoV-2 virus, which could take until 2023 or longer, given the logistical challenges of getting a vaccine from the manufacturing plant into people’s arms. 

Resources 

• Bloomberg Vaccine Global Distribution Tracker – This site, updated daily, not only tracks where vaccines are going but also provides a solid understanding of which vaccines have been approved and how many doses have been administered in countries around the world. 

• Launch & Scale Speedometer – This site, created by the Duke Global Health Innovation Center, provides a weekly update on COVID-19 vaccine research and the global distribution effort. 

• COVID-19 vaccine country readiness and delivery – WHO’s page detailing which countries are receiving vaccines 

• COVID-19 Tracker – COVID-19 clinical trials and treatments worldwide, updated daily; created by associate professor Nicole E. Basta and professor Erica E. M. Moodie in the department of epidemiology and biostatistics in the School of Population and Global Health at McGill University. 

• Coronavirus Vaccine Tracker (Global) – Created by the New York Times and updated daily. 

• Variants of the virus that cause COVID-19 – Centers for Disease Control and Prevention. For the moment, this is the best national tracker of variants that were first identified outside the U.S. and are now circulating domestically. 

• Africa Centres for Disease Control and Prevention COVID-19 – Africa’s CDC tracking of the virus and vaccinations. https://africacdc.org/covid-19/ 

• Unprotected African health workers die as rich countries buy up COVID-19 Vaccines (Science) — How vaccine inequality is unfairly impacting Africa. 

• COVAX: how will Covid vaccines be shared with poorer countries? (BBC) – Good article explaining what COVAX is and how it will work. 

• America’s extra vaccine doses could be key to global supply (Axios) – Explainer of how the U.S. can support COVAX, without diverting from the U.S.’s vaccine supply. 

• Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation and deployment (Lancet) — A detailed explanation of why it is going to be so challenging to vaccinate the world. All the authors on this article could be potential sources for reporters to speak with on understanding global health. 

• As China and Russia seek to boost their global influence, analysts warn vaccine diplomacy is here to stay (CNBC) — How China and Russia have sought to take advantage of the U.S. absence in international pandemic efforts during the past year. 

• Chinese vaccine arrives in first European Union nation (the Hill) — More on China and vaccine diplomacy. 

• How Russian vaccine Sputnik-V spread through Latin America (CNN) — More on Russia and vaccine diplomacy. 

• COVID: Why is EU’s vaccine roll out so slow? (BBC) — Articles showing the U.S. isn’t alone in having difficulty with their vaccine rollouts. 

• Dr Fauci: variants reveal COVID-19 vaccination as a global job (AMA News) — Fauci explains on Feb. 9, the imperative of global vaccination to slow the development of variants. 

Experts 

• Amesh Adalja, M.D., FIDSA, senior associate at the Johns Hopkins Bloomberg School of Public Health’s Center for Health Security, an expert on global health and infectious diseases. Email: aadalja1@jhu.edu 

• Ashley Arabasadi, co-chair of the Global Health Security Roundtable and senior external affairs manager at Management Sciences for Health, global health and humanitarian expert, Contact via her media person, Jordan Cordiza 

• Barry Bloom, professor of public health, immunology and infectious diseases, at Harvard’s T.H. Chan School of Public Health. Email: bbloom@hsph.harvard.edu 

• Luciana Borio, vice president, In-Q-Tel, former director for medical and biodefense preparedness policy under former President Trump, Email: info@iqt.org 

• Ezekiel Emanuel, vice provost for global initiatives, professor of health policy at University of Pennsylvania, member of the Biden administration COVID-19 transition team and an international health expert, Email: vp-global@upenn.edu  

• Rebecca Katz, Ph.D., M.P.H., director of the Center for Global Health Science and Security at Georgetown University and associate professor of international health, member of the Biden administration COVID-19 transition team, Email: Rebecca.Katz@georgetown.edu 

• Carolyn Reynolds, senior associate at the Global Health Policy Center at the Center for Strategic and International Studies and co-founder of the Pandemic Action Network. Expert in global health and pandemic preparedness. Email: creynoldsdc@gmail.com

• Krutika Kuppalli, MD, FIDSA, Vice Chair, Global Health Committee—Infectious Diseases Society of America, Assistant Professor, Division of Infectious Diseases, Medical University of South Carolina , Team Lead, INDIA COVID SOS, Email: kuppalli@musc.edu  

• Dawd Siraj, MD, FIDSA, Member, Global Health Committee—Infectious Diseases Society of America, Professor of Medicine, Division of Infectious Diseases, University of Wisconsin-Madison, Associate Program Director, Infectious Disease Fellowship Program, University of Wisconsin-Madison, Email: dssiraj@medicine.wisc.edu 

• Krishna Udayakumar, director of the Duke University Global Health Innovation Center, global health expert, Email: ku@duke.edu